Becker's Healthcare September 30, 2022
The first drugs negotiated by Medicare are likely to be blood thinners, diabetes treatments and cancer drugs, physicians predicted in a Sept. 30 article for Health Affairs.
Medicare will begin negotiating prices for certain drugs as part of the Inflation Reduction Act. These changesbegin rolling out in 2023, with the agency negotiating prices for 10 drugs, which are set to go into effect in 2026.
Certain criteria dictate which drugs Medicare can negotiate for — drugs must have been on the market for at least seven years, or 11 years for biologics. These drugs also must be single-source, with no generics available.
Based on these criteria, Micah Johnson, MD, Rahul Nayak, MD, and Sanjay Kishore, MD, predicted which...